Adjuvant S-1 extends OS in biliary tract cancers

被引：0
|
作者：
Romero, Diana
机构：
[1] Nature Reviews Clinical Oncology,
来源：
NATURE REVIEWS CLINICAL ONCOLOGY | 2023年 / 20卷 / 3期
关键词：
D O I：
10.1038/s41571-023-00738-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：138 / 138
页数：1
相关论文
共 50 条
  • [1] Adjuvant S-1 extends OS in biliary tract cancers
    Diana Romero
    Nature Reviews Clinical Oncology, 2023, 20 : 138 - 138
  • [2] ADJUVANT S-1 THERAPY FOR PATIENTS WITH RESECTED BILIARY TRACT CANCER
    Konishi, Masaru
    Ikeda, Masafumi
    Nakachi, Kohei
    ANNALS OF ONCOLOGY, 2014, 25
  • [3] Feasibility study of postoperative adjuvant chemotherapy with S-1 in patients with biliary tract cancer
    Nakachi, Kohei
    Konishi, Masaru
    Ikeda, Masafumi
    Shimada, Kazuaki
    Okusaka, Takuji
    Saiura, Akio
    Ishii, Hiroshi
    Sugiyama, Masanori
    Furuse, Junji
    Sakamoto, Hirohiko
    Shimamura, Tomotaka
    Ohta, Takehiro
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2018, 23 (05) : 894 - 899
  • [4] Adjuvant therapy of biliary tract cancers
    Kefas, Joanna
    Bridgewater, John
    Vogel, Arndt
    Stein, Alexander
    Primrose, John
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2023, 15
  • [5] Adjuvant Therapy for Biliary Tract Cancers
    Horgan, Anne M.
    Knox, Jennifer J.
    JOURNAL OF ONCOLOGY PRACTICE, 2018, 14 (12) : 701 - +
  • [6] Feasibility study of postoperative adjuvant chemotherapy with S-1 in patients with biliary tract cancer
    Kohei Nakachi
    Masaru Konishi
    Masafumi Ikeda
    Kazuaki Shimada
    Takuji Okusaka
    Akio Saiura
    Hiroshi Ishii
    Masanori Sugiyama
    Junji Furuse
    Hirohiko Sakamoto
    Tomotaka Shimamura
    Takehiro Ohta
    International Journal of Clinical Oncology, 2018, 23 : 894 - 899
  • [7] Feasibility of adjuvant S-1 chemotherapy after major hepatectomy for biliary tract cancers: An exploratory subset analysis of JCOG1202
    Kobayashi, Shogo
    Nakachi, Kohei
    Ikeda, Masafumi
    Konishi, Masaru
    Ogawa, Gakuto
    Uesaka, Katsuhiko
    Yanagimoto, Hiroaki
    Morinaga, Soichiro
    Wada, Hiroshi
    Shimada, Kazuaki
    Takahashi, Yu
    Nakagohri, Toshio
    Gotoh, Kunihito
    Kamata, Ken
    Shimizu, Yasuhiro
    Ajiki, Tetsuo
    Kawamoto, Yasuyuki
    Ueno, Makoto
    Okusaka, Takuji
    Furuse, Junji
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [8] Feasibility of S-1 adjuvant chemotherapy after major hepatectomy for biliary tract cancers: An exploratory subset analysis of JCOG1202
    Kobayashi, Shogo
    Nakachi, Kohei
    Ikeda, Masafumi
    Konishi, Masaru
    Ogawa, Gakuto
    Sugiura, Teiichi
    Yanagimoto, Hiroaki
    Morinaga, Soichiro
    Wada, Hiroshi
    Shimada, Kazuaki
    Takahashi, Yu
    Nakagohri, Toshio
    Kamata, Ken
    Shimizu, Yasuhiro
    Ajiki, Tetsuo
    Hirano, Satoshi
    Gotohda, Naoto
    Ueno, Makoto
    Okusaka, Takuji
    Furuse, Junji
    EJSO, 2024, 50 (01):
  • [9] Outcome of Adjuvant Therapy in Biliary Tract Cancers
    McNamara, Mairead G.
    Walter, Thomas
    Horgan, Anne M.
    Amir, Eitan
    Cleary, Sean
    McKeever, Elizabeth L.
    Min, Trisha
    Wallace, Elaine
    Hedley, David
    Krzyzanowska, Monika
    Moore, Malcolm
    Gallinger, Steven
    Greig, Paul
    Serra, Stefano
    Dawson, Laura A.
    Knox, Jennifer J.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2015, 38 (04): : 382 - 387
  • [10] Phase I study of adjuvant gemcitabine or S-1 in patients with biliary tract cancers undergoing major hepatectomy: KHBO1003 study
    Shogo Kobayashi
    Hiroaki Nagano
    Daisuke Sakai
    Hidetoshi Eguchi
    Etsuro Hatano
    Masashi Kanai
    Satoru Seo
    Kojiro Taura
    Yutaka Fujiwara
    Tetsuo Ajiki
    Shigekazu Takemura
    Shoji Kubo
    Hiroaki Yanagimoto
    Hideyoshi Toyokawa
    Akihito Tsuji
    Hiroaki Terajima
    Satoshi Morita
    Tatsuya Ioka
    Cancer Chemotherapy and Pharmacology, 2014, 74 : 699 - 709
12345